Buy (150 RUB)
Generate QR code
Open Access
Subscription or Fee Access
Neurological manifestations of COVID-19 in a five-year-old child
https://doi.org/10.21508/1027-4065-2022-67-4-86-92
Abstract
A new coronavirus infection (COVID-19, Corona Virus Disease 2019) is a disease caused by the SARS-CoV-2 virus, presenting as both a mild acute respiratory viral infection and a severe form, with damage to various organs and systems. In children under 16 years of age infected with SARS-CoV-2, the vast majority of cases were mild, without marked neurological manifestations.
This paper describes a case of acute disseminated encephalomyelitis in a five-year-old child associated with SARS-CoV-2, which caused difficulties in the differential diagnosis with demyelinating diseases and hereditary pathology. The disease was diagnosed in a family where both parentswere diagnosedwith COVID-19 by polymerase chain reaction (PCR).The CNSlesionwasrepresented by severe central hemiparesis, involvement of some cranial nerves, with impaired pelvic organ function. During the treatment there was a positive dynamicsin the somatic and neurologicalstatus. The patient was discharged for outpatient treatment with satisfactory rehabilitation potential.
SARS-CoV-2 lesions of the nervous system in children can lead to life-threatening and fatal conditions. Timely diagnosis and a comprehensive approach to the management of a child with encephalomyelitis made it possible to avoid adverse effects of the disease and improve the rehabilitation prognosis.
About the Authors
L. A. Balykova
Ogarev National Research Mordovia State University
Russian Federation
Russian Federation
Saransk
I. V. Boynova
Ogarev National Research Mordovia State University
Russian Federation
Russian Federation
Saransk
V. N. Ignatyev
Ogarev National Research Mordovia State University
Russian Federation
Russian Federation
Saransk
O. I. Ignatieva
Ogarev National Research Mordovia State University
Russian Federation
Russian Federation
Saransk
References
1. Carod-Artal F.J. Neurological complications of coronavirus and COVID-19. Rev Neurol 2020; 70(9): 311-322. DOI: 10.33588/rn.7009.2020179
2. Belopasov V.V., Yashu Y., Samoylova E.M., Baklaushev V.P. Nervous system damage in COVID-19. Clinical Practice 2020; 11(2): 60-80. DOI: 10.17816/clinpract34851
3. Voytenkov V.B., Ekusheva E.V. To the question of neurotropicity and neuroinvasiveness of coronaviruses. Clinical Practice 2020; 11(2): 81-86. DOI: 10.17816/clinpract34890
4. Merkulov Yu.A., Kolyak E.V., Samokhvalov R.I., Merkulova D.M., Kostenko E.V., Piatkov A.A. et al. Neuroinvasive potential of SARS-CoV-2 and topical aspects of neurorehabilitation in COVID-19 pandemic conditions. Analytical literature review. M., GAUZ MNPC MRVSM DZM, 2020; 53 (in Russ.)
5. Principi N., Esposito S. Are we sure that the neurological impact of COVID 19 in childhood has not been underestimated? Ital J Pediatr 2021; 47(1): 191. DOI: 10.1186/s13052-021-01144-y
6. Lin J.E., Asfour A., Sewell T.B., Hooe B., Pryce P., Earley C. et al. Neurological issues in children with COVID-19. Neurosci Lett 2021; 743: 135567. DOI: 10.1016/j.neulet.2020.135567
7. Alharbi M., Kazzaz Y.M., Hameed T., Alqanatish J., Alkhalaf H., Alsadoon А. et al. SARS-CoV-2 infection in children, clinical characteristics, diagnostic findings and therapeutic interventions at a tertiary care center in Riyadh, Saudi Arabia. J Infect Public Health 2021; 14(4): 446-453. DOI: 10.1016/j.jiph.2020.12.034
8. Provisional Methodological Recommendations «Prevention, diagnosis and treatment of emerging coronavirus infection (COVID-19). Version 9» (approved by the Ministry of Health of the Russian Federation on 26 October 2020 (in Russ) http://pervaya-pomoshh.net/versiya-9-metodicheskie-rekomendatsii-minzdrava-po-koronavirusu-ot-26-10-2020
9. Needham E., Chou S., Coles A., Menon D. Neurological Implications of COVID-19 Infections. Neurocritical Care 2020; 32(3): 667-671. DOI: 10.1007/s12028-020-00978-4
10. Guo Y., Cao Q., Hong Z., Tan Y., Chen S., Jin H. et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak — an update on the status. Mil Med Res 2020; 7: 11. DOI: 10.1186/s40779-020-00240-0
11. Maury A., Lyoubi A., Peiffer-Smadja N., Broucker T., Meppiel E. Neurological manifestations associated with SARSCoV-2 and other coronaviruses: A narrative review for clinicians. Rev Neurol (Paris) 2021; 177(1-2): 51-64. DOI: 10.1016/j.neurol.2020.10.001
12. Veleri S. Neurotropism of SARS-CoV-2 and neurological diseases of the central nervous system in COVID-19 patients. Exp Brain Res 2022; 240(1): 9-25. DOI: 10.1007/s00221-021-06244-z
13. Lechien J.R., Chiesa-Estomba C.M., De Siati D.R., Horoi M., Le Bon S., Rodriguezet А. et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol 2020; 277(8): 2251-2261. DOI: 10.1007/s00405-020-05965-1
14. Galougahi M., Ghorbani J., Bakhshayeshkaram M., Naeini A.S., Haseli S. Olfactory Bulb Magnetic Resonance Imaging in SARS-CoV-2-Induced Anosmia: The First Report. Acad Radiol 2020; 27(6): 892-893. DOI: 10.1016/j.acra.2020.04.002
15. Sharifian-Dorche M., Huot P., Osherov M., Wen D., Saveriano А., Giacomini P. Neurological complications of coronavirus infection; a comparative review and lessons learned during the COVID-19 pandemic. J Neurol Sci 2020; 417: 117085. DOI: 10.1016/j.jns.2020.117085
16. Roy D., Ghosh R., Dubey S., Dubey M.J., Benito-León J., Ray B.K. et al. Neurological and Neuropsychiatric Impacts of COVID-19 Pandemic. Can J Neurol Sci 2021; 48(1): 9-24. DOI: 10.1017/cjn.2020.173
17. Аbdel-Mannan O., Eyre M., Löbel U., Bamford A., Eltze С., Hameed B. et al. Neurologic and Radiographic Findings Associated With COVID-19 Infection in Children. JAMA Neurol 2020; 77(11): 1440-1445. DOI: 10.1001/jamaneurol.2020.2687
18. Poyiadji N., Shahin G., Noujaim D., Stone M., Patel S., Griffith B. COVID-19-associated Acute Hemor-rhagic Necrotizing Encephalopathy: Imaging Features. Radiology 2020; 296(2): E119-E120. DOI: 10.1148/radiol.2020201187
19. Wong F., Simon E., Zimmerman R., Wang H., Toh C., Ngl S. Acute necrotizing encephalopathy of childhood: correlation of MR findings and clinical outcome. AJNR Am J Neuroradiol 2006; 27(9): 1919-1923
20. Fedin A.I. Neurological clinical pathology associated with COVID-19. Neurology and neurosurgery. Eastern Europe 2020; 10(2): 312-329. DOI: 10.1016/S1474-4422(20)30221-0
21. Moriquchi T., Harii N., Goto J., Harada D., Sugawara H., Takaminoet J. et al. A first of meningitis/encephalitis associated with SARS-Coronavirus-2. International J Infect Dis 2020; 94: 54-58. DOI: 10.1016/j.ijid.2020.03.062
22. Lindan C.E., Mankad K., Ram D., Kociolek L.К., Silvera V.M., Boddaertet N. et al., ASPNR PECOBIG Collaborator Group. Neuroimaging manifestations in children with SARSCoV-2 infection: a multinational, multicentre collaborative study. Lancet Child Adolesc Health 2021 ;5(3): 167-177. DOI: 10.1016/S2352-4642(20)30362-X
23. Pascual-Goñi E., Fortea J., Martínez-Domeño A., Rabella N., Tecame М., Gómez-Olivaet С. et al. COVID19-associated ophthalmoparesis and hypothalamic involvement. Neurol Neuroimmunol Neuroinflamm 2020; 7(5): e823. DOI: 10.1212/NXI.0000000000000823
24. Dinkin M., Gao V., Kahan J. Bobker S., Simonetto М., Wechsler Р. et al. COVID-19 presenting with ophthalmoparesis from cranial nerve palsy. Neurology 2020; 95(5): 221-223. DOI: 10.1212/WNL.0000000000009700
25. Fernández-Domínguez J., Аmeijide-Sanluis Е., García-Cabo С., García-Rodríguez R., Mateos V. Miller-Fisher-like syndrome related to SARS-CoV-2 infection (COVID 19). Neurol 2020; 267(9): 2495-2496. DOI: 10.1007/s00415-020-09912-2
26. Lantos J.E., Strauss S.B., Lin E. COVID-19-Associated Miller Fisher Syndrome: MRI Findings. AJNR Am J Neuroradiol 2020; 41(7): 1184-1186. DOI: 10.3174/ajnr.A6609
27. Ray A. Miller Fisher syndrome and COVID-19: is there a link? BMJ Case Reports 2020; 13(8): e236419. DOI: 10.1136/bcr-2020-236419
28. Zharkova M.S., Tikhonov I.N., Efremova I.V., Ondos Sh.A., Nadinskaya M.Yu., Ivashkin V.T. Isolated bitemporal hemianopsia in a patient with COVID-19 infection. Sechenovsky Vestnik 2020; 11(2): 92-98. (in Russ.) DOI: 10.47093/2218-7332.2020.11.2.92-98
29. Mao L., Wang М., Chen S., Hu Y., Chen S., He Q. et al. Neurological Manifestations of Hospitalized Patients with COVID-19 in Wuhan, China: a retrospective case series. JAMA Neurol 2020; 77(6): 683-690. DOI: 10.1001/jamaneurol.2020.1127
30. Yachou Y., Idrissi A. El., Belapasov V., Ait Benali S. Neuroinvasion, neuro-tropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients. Neurol Sci 2020; 41(10): 2657- 2669. DOI: 10.1007/s10072-020-04575-3
31. Águila-Gordo D., Flores-Barragán J.M., Ferragut-Lloret F., Portela-Gutierrez J., LaRosa-Salas B., Porras-Leal L. et al. Acute mye-litis and SARS-CoV-2 infection. A new etiology of myelitis? J Clin Neurosci 2020; 80: 280-281. DOI: 10.1016/j.jocn
32. Lindan C.E., Mankad K., Ram D., Kociolek L.K., Silvera V.M., Boddaert N. et al. ASPNR PECOBIG Collaborator Group. Neuroimaging manifestations in children with SARSCoV-2 infection: a multinational, multicentre collaborative study. Lancet Child Adolesc Health 2021; 5(3): 167-177. DOI: 10.1016/S2352-4642(20)30362-X
33. Astapov A.A., Kudin A.P., Yasinskaya L.I. Encephalitis in children. Minsk; BGMU, 2018; 46. (in Russ.)
34. Methodical recommendations «Features of clinical manifestations and treatment of disease caused by a new coronavirus infection (COVID-19) in children. Version 2» (approved by the Ministry of Health of the Russian Federation on 03.07.2020) (in Russ.) https://static-0.minzdrav.gov.ru/system/attachments/attaches/000/050/914/original/03062020_дети_COVID-19_v2.pdf
35. Kogan E.A., Berezovsky Y.S., Protsenko D.D. Baghdasaryan T. R., Gretzov E. M., Demura S.A. et al. Pathological anatomy of infection caused by SARS-CoV-2. Forensic Medicine 2020; 6(2): 8-30. DOI: 10.19048/2411-8729-2020-6- 2-8-30
36. Williamson E., Walker А., Bhaskaran К., Bacon S., Bates C., Mortonet C. et al. Factors associated with COVID-19-related death using Open SAFELY 2020; 584(7821): 430-436. DOI: 10.1038/s41586-020-2521-4
37. Ray S.T.J., Abdel-Mannan O., Sa M., Slater R., Forgeron P., Palermo T. et al. CoroNerve study group. Lancet Child Adolesc Health 2021; 5(9): 631-641. DOI: 10.1016/S2352-4642(21)00193-0
Review
For citations:
Balykova L.A., Boynova I.V., Ignatyev V.N., Ignatieva O.I. Neurological manifestations of COVID-19 in a five-year-old child. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics). 2022;67(4):86-92. (In Russ.) https://doi.org/10.21508/1027-4065-2022-67-4-86-92
Views:
428
Email this article 